These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35507915)

  • 21. Proarrhythmic changes in human cardiomyocytes during hypothermia by milrinone and isoprenaline, but not levosimendan: an experimental in vitro study.
    Selli AL; Ghasemi M; Watters T; Burton F; Smith G; Dietrichs ES
    Scand J Trauma Resusc Emerg Med; 2023 Oct; 31(1):61. PubMed ID: 37880801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
    Nag P; Chowdhury SR; Behera SK; Das M; Narayan P
    J Cardiothorac Vasc Anesth; 2023 Jun; 37(6):972-979. PubMed ID: 36906394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ambulatory Intravenous Inotropic Support and or Levosimendan in Pediatric and Congenital Heart Failure: Safety, Survival, Improvement, or Transplantation.
    Apostolopoulou SC; Vagenakis GA; Tsoutsinos A; Kakava F; Rammos S
    Pediatr Cardiol; 2018 Oct; 39(7):1315-1322. PubMed ID: 29777282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Levosimendan: a unique approach to the treatment of heart failure.
    Nawarskas JJ; Anderson JR
    Heart Dis; 2002; 4(4):265-71. PubMed ID: 12147186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
    Mehta RH; Leimberger JD; van Diepen S; Meza J; Wang A; Jankowich R; Harrison RW; Hay D; Fremes S; Duncan A; Soltesz EG; Luber J; Park S; Argenziano M; Murphy E; Marcel R; Kalavrouziotis D; Nagpal D; Bozinovski J; Toller W; Heringlake M; Goodman SG; Levy JH; Harrington RA; Anstrom KJ; Alexander JH;
    N Engl J Med; 2017 May; 376(21):2032-2042. PubMed ID: 28316276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.
    Lechner E; Hofer A; Leitner-Peneder G; Freynschlag R; Mair R; Weinzettel R; Rehak P; Gombotz H
    Pediatr Crit Care Med; 2012 Sep; 13(5):542-8. PubMed ID: 22622649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Levosimendan and dobutamine have a similar profile for potential risk for cardiac arrhythmias during 24-hour infusion in patients with acute decompensated heart failure].
    Tek M; Cavuşoğlu Y; Demirüstü C; Birdane A; Ünalır A; Görenek B; Göktekin Ö; Ata N
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):334-40. PubMed ID: 21200103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG; Lorsomradee S; Cromheecke S; Van der Linden PJ
    Anesth Analg; 2007 Apr; 104(4):766-73. PubMed ID: 17377079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levosimendan Versus Milrinone and Release of Myocardial Biomarkers After Pediatric Cardiac Surgery: Post Hoc Analysis of Clinical Trial Data.
    Thorlacius EM; Vistnes M; Ojala T; Keski-Nisula J; Molin M; Romlin BS; Synnergren M; Ricksten SE; Wåhlander H; Castellheim A
    Pediatr Crit Care Med; 2021 Jul; 22(7):e402-e409. PubMed ID: 33739957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levosimendan Versus Milrinone for Inotropic Support in Pediatric Cardiac Surgery: Results From a Randomized Trial.
    Thorlacius EM; Wåhlander H; Ojala T; Ylänen K; Keski-Nisula J; Synnergren M; Romlin BS; Ricksten SE; Castellheim A
    J Cardiothorac Vasc Anesth; 2020 Aug; 34(8):2072-2080. PubMed ID: 32201198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel biologic mechanisms of levosimendan and its effect on the failing heart.
    Parissis JT; Andreadou I; Bistola V; Paraskevaidis I; Filippatos G; Kremastinos DT
    Expert Opin Investig Drugs; 2008 Aug; 17(8):1143-50. PubMed ID: 18616411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A promising new inotrope: levosimendan.
    Fotbolcu H; Duman D
    Anadolu Kardiyol Derg; 2010 Apr; 10(2):176-82. PubMed ID: 20382619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan.
    Haikala H; Kaheinen P; Levijoki J; Lindén IB
    Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
    Follath F; Cleland JG; Just H; Papp JG; Scholz H; Peuhkurinen K; Harjola VP; Mitrovic V; Abdalla M; Sandell EP; Lehtonen L;
    Lancet; 2002 Jul; 360(9328):196-202. PubMed ID: 12133653
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevation of plasma milrinone concentrations in stage D heart failure associated with renal dysfunction.
    Cox ZL; Calcutt MW; Morrison TB; Akers WS; Davis MB; Lenihan DJ
    J Cardiovasc Pharmacol Ther; 2013 Sep; 18(5):433-8. PubMed ID: 23695773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of temperature on the positive inotropic effect of levosimendan, dobutamine and milrinone.
    Rieg AD; Schroth SC; Grottke O; Hein M; Ackermann D; Rossaint R; Schälte G
    Eur J Anaesthesiol; 2009 Nov; 26(11):946-53. PubMed ID: 19687740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale and design of a randomized, double-blind, placebo controlled multicenter trial to study efficacy, security, and long term effects of intermittent repeated levosimendan administration in patients with advanced heart failure: LAICA study.
    García-González MJ; de Mora-Martín M; López-Fernández S; López-Díaz J; Martínez-Sellés M; Romero-García J; Cordero M; Lara-Padrón A; Marrero-Rodríguez F; del Mar García-Saiz M; Aldea-Perona A;
    Cardiovasc Drugs Ther; 2013 Dec; 27(6):573-9. PubMed ID: 23887741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of perioperative infusion of levosimendan in patients with compromised cardiac function undergoing open-heart surgery: importance of early use.
    Tasouli A; Papadopoulos K; Antoniou T; Kriaras I; Stavridis G; Degiannis D; Geroulanos S
    Eur J Cardiothorac Surg; 2007 Oct; 32(4):629-33. PubMed ID: 17702589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.